Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 06, 2023

SELL
$160.2 - $179.79 $9,451 - $10,607
-59 Reduced 12.07%
430 $76,000
Q3 2022

Nov 10, 2022

SELL
$161.33 - $179.52 $145,035 - $161,388
-899 Reduced 64.77%
489 $80,000
Q2 2022

Aug 11, 2022

BUY
$168.19 - $186.01 $86,449 - $95,609
514 Added 58.81%
1,388 $247,000
Q4 2021

Feb 11, 2022

SELL
$155.93 - $173.01 $19,023 - $21,107
-122 Reduced 12.25%
874 $150,000
Q3 2021

Nov 15, 2021

SELL
$161.5 - $179.47 $80,104 - $89,017
-496 Reduced 33.24%
996 $160,000
Q2 2021

Aug 11, 2021

SELL
$159.48 - $171.07 $160,915 - $172,609
-1,009 Reduced 40.34%
1,492 $247,000
Q1 2021

May 13, 2021

BUY
$153.07 - $170.48 $29,389 - $32,732
192 Added 8.32%
2,501 $410,000
Q4 2020

Feb 10, 2021

SELL
$137.11 - $157.38 $37,293 - $42,807
-272 Reduced 10.54%
2,309 $363,000
Q3 2020

Nov 04, 2020

SELL
$140.38 - $153.83 $94,616 - $103,681
-674 Reduced 20.71%
2,581 $382,000
Q2 2020

Aug 12, 2020

SELL
$128.81 - $155.51 $115,542 - $139,492
-897 Reduced 21.6%
3,255 $456,000
Q1 2020

May 08, 2020

BUY
$111.14 - $153.99 $335,420 - $464,741
3,018 Added 266.14%
4,152 $543,000
Q4 2019

Feb 13, 2020

SELL
$127.5 - $146.44 $84,660 - $97,236
-664 Reduced 36.93%
1,134 $167,000
Q3 2019

Nov 14, 2019

BUY
$126.95 - $142.14 $220,004 - $246,328
1,733 Added 2666.15%
1,798 $233,000
Q2 2019

Aug 14, 2019

SELL
$131.15 - $144.24 $73,575 - $80,918
-561 Reduced 89.62%
65 $9,000
Q1 2019

May 14, 2019

SELL
$125.72 - $139.79 $72,163 - $80,239
-574 Reduced 47.83%
626 $88,000
Q4 2018

Feb 13, 2019

SELL
$122.84 - $147.84 $42,134 - $50,709
-343 Reduced 22.23%
1,200 $155,000
Q3 2018

Oct 31, 2018

BUY
$121.58 - $142.88 $187,597 - $220,463
1,543 New
1,543 $213,000
Q2 2018

Aug 03, 2018

SELL
$119.4 - $131.76 $41,431 - $45,720
-347 Closed
0 $0
Q3 2017

Nov 13, 2017

BUY
$129.47 - $135.38 $44,926 - $46,976
347
347 $45,000

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $404B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Harvest Fund Management Co., LTD Portfolio

Follow Harvest Fund Management Co., LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Harvest Fund Management Co., LTD, based on Form 13F filings with the SEC.

News

Stay updated on Harvest Fund Management Co., LTD with notifications on news.